Skip to contents

  4. Wall, James G; Burris, Howard A; Von Hoff, Daniel D; Rodriguez, Gladys; Kneuper-Hall, Rayna; Shaffer, Don; OʼRourke, Timothy; Brown, Thomas; Weiss, Geoffrey; Clark, Gary; McVea, Shirley; Johnson, Randall; Friedman, Carl; Smith, Brian; Mann, William S; Kuhn, John

    A phase I clinical and pharmacokinetic study of the topoisomerase I inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 days

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Ovid Technologies (Wolters Kluwer Health), 1992

    Published in: Anti-Cancer Drugs, 3 (1992) 4, Seite 337-346